This regulation of STMN1 in turn affects apoptosis, epithelial-mesenchymal transition, metastasis, and chemoresistance to doxorubicin in triple-negative breast cancer, thereby altering the tumor microenvironment [48]. The gene discussed is STMN1; the disease is neoplasm.